GPT Healthcare EV/EBITDA Ratio

GPT Healthcare Ltd Enterprise Value to EBITDA Ratio

The GPT Healthcare Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate GPT Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the GPT Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

GPT Healthcare Ltd (NSE: GPTHEALTH, BSE: 544131) is currently trading at ₹124.60, with a market capitalization of ₹10.11B. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the GPT Healthcare Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

GPT Healthcare Ltd Enterprise Value to EBITDA Ratio Current Value

The current GPT Healthcare Ltd Enterprise Value to EBITDA Ratio stands at 14.30.

The GPT Healthcare Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

GPT Healthcare Ltd Enterprise Value to EBITDA Ratio Historical Trend

The GPT Healthcare Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

• 2024: 14.30
• 2023: 16.07
• 2020: 0
• 2019: 0
• 2018: 0

The decline in GPT Healthcare Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What GPT Healthcare Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The GPT Healthcare Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of GPT Healthcare Ltd.

GPT Healthcare Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The GPT Healthcare Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking GPT Healthcare Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of GPT Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.